Gene editing is already being used to treat a handful of rare genetic diseases; however, most therapies involve breaking or ...

More than 1,000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study, ...

Synthetic biologists from Yale were able to re-write the genetic code of an organism - a novel genomically recoded organism (GRO) with one stop codon - using a cellular platform that they developed ...

Targeting mitochondrial retrograde signaling may therefore be promising in the treatment or prevention of metabolic disorders ...

Scientists have discovered that the peptide hormone adrenomedullin plays a pivotal role in obesity-related type 2 diabetes, ...

Adrenomedullin disrupts insulin signaling in blood vessels, leading to systemic insulin resistance in obesity-associated type 2 diabetes.

Genetic engineering deployed to insert gene for human insulin into a bacterium, thus harnessing the substance for widespread ...